BSH/ISH 2016 | A registry for AML in pregnancy – why it is important
Sahra Ali
• 18 Apr 2016
Sahra Ali, MD from Queen’s Centre Castle Hill Hospital, Hull, UK discusses the need to set up a registry for acute myeloid leukemia (AML) in pregnancy. According to Dr Ali, a registry will become more important in future as women are getting pregnant later in life, which means that the risk of developing AML is greater. The registry will not only register the incidence of acute leukemia in pregnancy but also the management of the cases, which will help inform guidelines.
Recorded at the 2016 Annual Meeting of the British Society of Haematology (BSH) and International Society of Hematology (ISH) held in Glasgow, Scotland.
